SHUBHAM PANT to Endometrial Neoplasms
This is a "connection" page, showing publications SHUBHAM PANT has written about Endometrial Neoplasms.
Connection Strength
0.024
-
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer. Br J Cancer. 2020 11; 123(11):1590-1598.
Score: 0.024